Fact CheckerSign in

NCT07555847Completed

Effect of Kinesiotaping on Tremor in People With Parkinson's Disease

Effect of Kinesiotaping on Hand Tremor in Patients With Parkinson's Disease: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 29 Apr 2026

Brief summary (registry, in English)

The goal of this clinical trial is to learn whether adding kinesiotaping to a strengthening and stretching home-exercise program can reduce hand tremor and improve hand function in people with Parkinson's disease. The study will also examine how true kinesiotaping compares with sham (placebo) taping and with exercise alone in improving tremor frequency, grip strength, fine motor skills, motor symptoms, daily living activities, and quality of life. Adults aged 18-80 with Parkinson's disease and hand tremor will be randomly assigned to one of three groups: Kinesiotaping + Exercise Group: Participants will receive therapeutic kinesiotaping applied to the forearm extensor muscles and wrist for 4 weeks (twice weekly), in addition to a home program of strengthening and stretching exercises. Sham Taping + Exercise Group: Participants will receive a placebo taping without tension that does not target specific muscles, along with the same exercise program. Exercise-Only Group: Participants will complete the same home-exercise program without any taping. Researchers will compare the three groups to see whether kinesiotaping provides additional benefits beyond exercise and whether it performs better than sham taping. Tremor frequency will be measured using an Apple Watch device, and hand strength, dexterity, motor symptoms, and quality of life will be assessed using validated clinical scales.

Status (registry)
Completed
Study type
Interventional
Enrollment
45 (actual)
First submitted
14 Apr 2026
Start date
1 Mar 2025
Primary completion date
1 Nov 2025
Lead sponsor
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
NCT number
NCT07555847

What you commit to

  • Study type: Interventional
  • Participants enrolled: 45
  • From 1 Mar 2025 to the primary completion date, 1 Nov 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Diagnosis of essential tremor or tremor due to causes other than Parkinson's disease
  • Advanced motor impairment (severe bradykinesia or dyskinesia)
  • History of allergic reaction to kinesiotaping materials
  • Presence of other neurological disorders causing tremor (e.g., ALS, multiple sclerosis, cerebellar disorders)
  • Severe psychiatric disorders (e.g., major depression, psychosis, severe anxiety)

Who the study is looking for

  • Diagnosis of idiopathic Parkinson's disease
  • Hoehn and Yahr stage 1-4
  • Presence of hand tremor
  • Mini-Mental State Examination (MMSE) score ≥ 23
  • Stable medical treatment for at least 3 months prior to enrollment and no planned changes during the study period
  • Age between 18 and 80 years
  • Ability to understand and provide written informed consent

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Health Sciences, Sultan 2. Abdulhamid Han Training and Research Hospital
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.